ティオコナゾールは,細胞の完全性を破壊することによって,抗結核作用を行います
Zhanpeng Chen1, Xiaoming Wang1, He Zhang1
1National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
European journal of pharmacology
|August 30, 2025
まとめ
ティオコナゾールは,結核 (TB) 菌株に対する強力な抗菌効果を示し,潜在的な新しい治療法を提供します. 病原体を破壊する
科学分野:
- 微生物学
- 薬物の発見
- 感染症
背景:
- 薬剤耐性結核 (TB) とヒト免疫不全ウイルス (HIV) の共感染は,新しい抗結核剤を必要とします.
- 従来型の結核治療は 長く毒性があり 耐性菌株に対して 効果が低下しています
研究 の 目的:
- ティオコナゾールの抗結核作用と抗菌メカニズムを調査する.
- Mycobacterium tuberculosis (Mtb) に対する新たな治療薬としてのチオコナゾールの評価
主な方法:
- Mtb H37RaとH37Rvに対するチオコナゾールの最小抑制濃度 (MIC) を決定した.
- Mtb H37Ra CYP121条件変異体とプリスティナミシンを用いてチオコナゾールの活性を評価した.
- ティオコナゾールで治療されたMtb細胞における形態学的変化と細胞内ATPレベルを調べた.
主要な成果:
- ティオコナゾールは,MIC 4μg/ mL (Mtb H37Ra) と 1μg/ mL (Mtb H37Rv) の有意な抗菌作用を示した.
- コレステロールまたはパルミチン酸を単一の炭素源として使用すると,Mtb H37Raに対するMICは2μg/mLに減少した.
- ティオコナゾール治療は細胞表面の浸透/膨らみを引き起こし,細胞内ATPレベルを約50%低下させ,細胞の完全性と脂質代謝の障害を示した.
結論:
- ティオコナゾールは,Mtbに対する強力な抗結核活性を示しています.
- この薬は,おそらく脂質代謝の阻害によって,細胞壁と膜の整合性を損なうことで効果を発揮するようです.
- ティオコナゾールは新しい抗結核薬の開発に有望な候補である.
さらに関連する動画
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
11.7K
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
3.2K
関連する概念動画
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
